GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Samsung BioLogics Co Ltd (XKRX:207940) » Definitions » COGS-to-Revenue

Samsung BioLogics Co (XKRX:207940) COGS-to-Revenue : 0.56 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Samsung BioLogics Co COGS-to-Revenue?

Samsung BioLogics Co's Cost of Goods Sold for the three months ended in Mar. 2024 was ₩526,749 Mil. Its Revenue for the three months ended in Mar. 2024 was ₩946,903 Mil.

Samsung BioLogics Co's COGS to Revenue for the three months ended in Mar. 2024 was 0.56.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Samsung BioLogics Co's Gross Margin % for the three months ended in Mar. 2024 was 44.37%.


Samsung BioLogics Co COGS-to-Revenue Historical Data

The historical data trend for Samsung BioLogics Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Samsung BioLogics Co COGS-to-Revenue Chart

Samsung BioLogics Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.73 0.64 0.54 0.51 0.51

Samsung BioLogics Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.52 0.51 0.51 0.51 0.56

Samsung BioLogics Co COGS-to-Revenue Calculation

Samsung BioLogics Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=1891824.206 / 3694588.767
=0.51

Samsung BioLogics Co's COGS to Revenue for the quarter that ended in Mar. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=526749.351 / 946903.319
=0.56

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Samsung BioLogics Co  (XKRX:207940) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Samsung BioLogics Co's Gross Margin % for the three months ended in Mar. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 526749.351 / 946903.319
=44.37 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.


Samsung BioLogics Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Samsung BioLogics Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Samsung BioLogics Co (XKRX:207940) Business Description

Traded in Other Exchanges
N/A
Address
125, Cheomdan-daero, Yeonsu-gu,, Incheon, KOR
Samsung BioLogics Co Ltd engaged in development and manufacturing of bio-healthcare products.The Company works namely in Process Development, cGMP Manufacturing, Aseptic Fill and Finish.

Samsung BioLogics Co (XKRX:207940) Headlines

No Headlines